Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1353588

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1353588

LAMEA Viscosupplementation Market Size, Share & Industry Trends Analysis Report By Application, By Product (Three Injection, Single Injection, and Five Injection), By End-use, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 126 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Viscosupplementation Market would witness market growth of 11.0% CAGR during the forecast period (2023-2030).

The high adoption of pain medications to treat osteoarthritis-related pain is anticipated to continue over the coming years, driving market growth. Personalized OA medications have been created, significantly improving the diagnosis, treatment, and monitoring of disease activity in osteoarthritis patients. Ease of measurement, suitable levels of sensitivity and specificity, and test methods that are easily interpretable by clinicians are essential characteristics of biomarkers with clinical relevance for a personalized approach to therapy for arthritis like rheumatoid arthritis (RA) and osteoarthritis (OA).

Using biomarkers to identify patients likely to react to particular medical therapies may boost treatment response rates and lower the risk of exposing patients to therapies that are unlikely to be beneficial or harmful treatment-related adverse effects. Combining distinct biomarkers and baseline clinical characteristics, such as age and sex, may improve efforts to personalise RA and OA treatment regimen.

Additionally, according to National Library of Medicine, the prevalence of overweight as well as obesity, respectively, falls in the range of 23.5-62.1 and 14.5-40.6 in the Middle East in 2022. According to the same source, Israel, Kuwait, and Syria had the highest rates of obesity and overweight people. The rise in the incidence of non-communicable diseases, such as obesity, may be attributed to changes in lifestyle over the previous few years, such as Arabic diets (high-calorie, fatty meals like fast food), alcohol drinking, and decreased physical activity. As a result of the age-standardized prevalence of OA along with obesity in the LAMEA region, the market will grow rapidly in the coming years.

The Brazil market dominated the LAMEA Viscosupplementation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $139.5 million by 2030. The Argentina market is showcasing a CAGR of 11.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.7% during (2023 - 2030).

Based on Application, the market is segmented into Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Others. Based on Product, the market is segmented into Three Injection, Single Injection, and Five Injection. Based on End-use, the market is segmented into Hospitals, and Orthopedic Clinics/ASCs. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Knee Osteoarthritis
  • Hand Osteoarthritis
  • Hip Osteoarthritis
  • Others

By Product

  • Three Injection
  • Single Injection
  • Five Injection

By End-use

  • Hospitals
  • Orthopedic Clinics/ASCs

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • DePuy Synthes (Johnson & Johnson)
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.
  • Ferring Holdings SA
  • F. Hoffmann-La Roche Ltd.
  • LG Chem Ltd. (LG Corporation)
  • Anika Therapeutics, Inc.
  • Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
  • Smith & Nephew PLC
  • Seikagaku Corp.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Viscosupplementation Market, by Application
    • 1.4.2 LAMEA Viscosupplementation Market, by Product
    • 1.4.3 LAMEA Viscosupplementation Market, by End-use
    • 1.4.4 LAMEA Viscosupplementation Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. LAMEA Viscosupplementation Market by Application

  • 4.1 LAMEA Knee Osteoarthritis Market by Country
  • 4.2 LAMEA Hand Osteoarthritis Market by Country
  • 4.3 LAMEA Hip Osteoarthritis Market by Country
  • 4.4 LAMEA Others Market by Country

Chapter 5. LAMEA Viscosupplementation Market by Product

  • 5.1 LAMEA Three Injection Market by Country
  • 5.2 LAMEA Single Injection Market by Country
  • 5.3 LAMEA Five Injection Market by Country

Chapter 6. LAMEA Viscosupplementation Market by End-use

  • 6.1 LAMEA Hospitals Market by Country
  • 6.2 LAMEA Orthopedic Clinics/ASCs Market by Country

Chapter 7. LAMEA Viscosupplementation Market by Country

  • 7.1 Brazil Viscosupplementation Market
    • 7.1.1 Brazil Viscosupplementation Market by Application
    • 7.1.2 Brazil Viscosupplementation Market by Product
    • 7.1.3 Brazil Viscosupplementation Market by End-use
  • 7.2 Argentina Viscosupplementation Market
    • 7.2.1 Argentina Viscosupplementation Market by Application
    • 7.2.2 Argentina Viscosupplementation Market by Product
    • 7.2.3 Argentina Viscosupplementation Market by End-use
  • 7.3 UAE Viscosupplementation Market
    • 7.3.1 UAE Viscosupplementation Market by Application
    • 7.3.2 UAE Viscosupplementation Market by Product
    • 7.3.3 UAE Viscosupplementation Market by End-use
  • 7.4 Saudi Arabia Viscosupplementation Market
    • 7.4.1 Saudi Arabia Viscosupplementation Market by Application
    • 7.4.2 Saudi Arabia Viscosupplementation Market by Product
    • 7.4.3 Saudi Arabia Viscosupplementation Market by End-use
  • 7.5 South Africa Viscosupplementation Market
    • 7.5.1 South Africa Viscosupplementation Market by Application
    • 7.5.2 South Africa Viscosupplementation Market by Product
    • 7.5.3 South Africa Viscosupplementation Market by End-use
  • 7.6 Nigeria Viscosupplementation Market
    • 7.6.1 Nigeria Viscosupplementation Market by Application
    • 7.6.2 Nigeria Viscosupplementation Market by Product
    • 7.6.3 Nigeria Viscosupplementation Market by End-use
  • 7.7 Rest of LAMEA Viscosupplementation Market
    • 7.7.1 Rest of LAMEA Viscosupplementation Market by Application
    • 7.7.2 Rest of LAMEA Viscosupplementation Market by Product
    • 7.7.3 Rest of LAMEA Viscosupplementation Market by End-use

Chapter 8. Company Profiles

  • 8.1 DePuy Synthes (Johnson & Johnson)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental & Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Sanofi S.A.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Zimmer Biomet Holdings, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 SWOT Analysis
  • 8.4 Ferring Holdings SA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 Research and Development Expense
    • 8.4.5 SWOT Analysis
  • 8.5 F. Hoffmann-La Roche Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 SWOT Analysis
  • 8.6 LG Chem Ltd. (LG Corporation)
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 SWOT Analysis
  • 8.7 Anika Therapeutics, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis
  • 8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 SWOT Analysis
  • 8.9 Smith & Nephew PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional and Segmental Analysis
    • 8.9.4 Research & Development Expense
    • 8.9.5 SWOT Analysis
  • 8.10. Seikagaku Corp.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Three Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Three Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Single Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Single Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Five Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Five Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
  • TABLE 27 LAMEA Viscosupplementation Market by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA Viscosupplementation Market by Country, 2023 - 2030, USD Million
  • TABLE 29 Brazil Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 30 Brazil Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 31 Brazil Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 32 Brazil Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 33 Brazil Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 34 Brazil Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 35 Brazil Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 36 Brazil Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 37 Argentina Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 38 Argentina Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 39 Argentina Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 40 Argentina Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 41 Argentina Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 42 Argentina Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 43 Argentina Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 44 Argentina Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 45 UAE Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 46 UAE Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 47 UAE Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 48 UAE Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 49 UAE Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 50 UAE Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 51 UAE Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 52 UAE Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 53 Saudi Arabia Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 54 Saudi Arabia Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 55 Saudi Arabia Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 56 Saudi Arabia Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 57 Saudi Arabia Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 58 Saudi Arabia Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 59 Saudi Arabia Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 60 Saudi Arabia Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 61 South Africa Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 62 South Africa Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 63 South Africa Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 64 South Africa Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 65 South Africa Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 66 South Africa Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 67 South Africa Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 68 South Africa Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 69 Nigeria Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 70 Nigeria Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 71 Nigeria Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 72 Nigeria Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 73 Nigeria Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 74 Nigeria Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 75 Nigeria Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 76 Nigeria Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 77 Rest of LAMEA Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 78 Rest of LAMEA Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 79 Rest of LAMEA Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 80 Rest of LAMEA Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 81 Rest of LAMEA Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 82 Rest of LAMEA Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 83 Rest of LAMEA Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 84 Rest of LAMEA Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 85 Key Information - DePuy Synthes
  • TABLE 86 Key Information - Sanofi S.A.
  • TABLE 87 key Information - Zimmer Biomet Holdings, Inc.
  • TABLE 88 key information - Ferring Holdings SA
  • TABLE 89 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 90 key information - LG Chem Ltd.
  • TABLE 91 Key Information - Anika Therapeutics, Inc.
  • TABLE 92 Key Information - Fidia Farmaceutici S.p.A.
  • TABLE 93 key Information - Smith & Nephew PLC
  • TABLE 94 Key Information - Seikagaku Corp.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 LAMEA Viscosupplementation Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting the Viscosupplementation Market
  • FIG 4 Porter's Five Force Analysis: Viscosupplementation Market
  • FIG 5 LAMEA Viscosupplementation Market share by Application, 2022
  • FIG 6 LAMEA Viscosupplementation Market share by Application, 2030
  • FIG 7 LAMEA Viscosupplementation Market by Application, 2019 - 2030, USD Million
  • FIG 8 LAMEA Viscosupplementation Market share by Product, 2022
  • FIG 9 LAMEA Viscosupplementation Market share by Product, 2030
  • FIG 10 LAMEA Viscosupplementation Market by Product, 2019 - 2030, USD Million
  • FIG 11 LAMEA Viscosupplementation Market share by End-use, 2022
  • FIG 12 LAMEA Viscosupplementation Market share by End-use, 2030
  • FIG 13 LAMEA Viscosupplementation Market by End-use, 2019 - 2030, USD Million
  • FIG 14 LAMEA Viscosupplementation Market share by Country, 2022
  • FIG 15 LAMEA Viscosupplementation Market share by Country, 2030
  • FIG 16 LAMEA Viscosupplementation Market by Country, 2019 - 2030, USD Million
  • FIG 17 Swot Analysis: DePuy Synthes
  • FIG 18 Swot Analysis: Sanofi S.A.
  • FIG 19 Swot Analysis: Zimmer Biomet Holdings, Inc.
  • FIG 20 Swot Analysis: Ferring Holdings SA
  • FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
  • FIG 22 Swot Analysis: LG Chem Ltd.
  • FIG 23 Swot Analysis: ANIKA THERAPEUTICS, INC.
  • FIG 24 Swot Analysis: FIDIA FARMACEUTICI S.P.A.
  • FIG 25 SWOT Analysis: Smith & Nephew PLC
  • FIG 26 Swot Analysis: SEIKAGAKU CORP.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!